Evidence map›Paper›PMID 24759942›Full record

ArticleJAMA surgery2014

Pressure control during preparation of saphenous veins.

Fan Dong Li, Susan Eagle, Colleen Brophy, Kyle M Hocking, Michael Osgood, Padmini Komalavilas, Joyce Cheung-Flynn

Open access · greenAbstract read
In one paragraph

Article in JAMA surgery, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
5.9field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 45 citations in OpenAlex.

  1. Impact of Graft Velocity on Saphenous Vein Graft Atherosclerosis after Coronary Artery Bypass Grafting.Annals of thoracic and cardiovascular surgery : official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia · 2024
    Trial
  2. Trial
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. A cell permeant phosphopeptide mimetic of Niban inhibits p38 MAPK and restores endothelial function after injury.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2020
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Fan Dong LiGeneral Hospital of Jinan Military District, Jinan, China.
Susan EagleDivision of Cardiothoracic Anesthesiology, Vanderbilt University Medical Center, Nashville, Tennessee.
Colleen BrophyDivision of Vascular Surgery, Vanderbilt University Medical Center, Nashville, Tennessee.
Kyle M HockingDivision of Vascular Surgery, Vanderbilt University Medical Center, Nashville, Tennessee.
Michael OsgoodDivision of Vascular Surgery, Vanderbilt University Medical Center, Nashville, Tennessee.
Padmini KomalavilasDivision of Vascular Surgery, Vanderbilt University Medical Center, Nashville, Tennessee.
Joyce Cheung-FlynnDivision of Vascular Surgery, Vanderbilt University Medical Center, Nashville, Tennessee.
Vanderbilt University Medical Center · USJinan Military General Hospital · CN

Funding

VANDERBILT UNIVERSITY CTSA FOR PEDIATRIC RESEARCHUL1RR024975 · NCRR · VANDERBILT UNIVERSITY · PI BERNARD, GORDON RAPHAEL · 2007 to 2011
$45.7M
The Vanderbilt Institute for Clinical and Translational Research (VICTR)UL1TR000445 · NCATS · VANDERBILT UNIVERSITY MEDICAL CENTER · PI BERNARD, GORDON RAPHAEL · 2012 to 2016
$41.4M
PREVENTION OF VEIN GRAFT SPASMR01HL070715 · NHLBI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI BROPHY, COLLEEN M · 2003 to 2021
$7.2M
Methods To Reduce Vein Harvest InjuryR01HL105731 · NHLBI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI CHEUNG-FLYNN, JOYCE · 2012 to 2015
$1.4M
Enhancing vein graft viabilityF32HL104965 · NHLBI · VANDERBILT UNIVERSITY · PI OSGOOD, MICHAEL JAMES · 2010 to 2012
$156k
NCATS NIH HHS UL1 TR000445NCATS NIH HHS UL1 TR000445-06NCRR NIH HHS UL1 RR024975NCRR NIH HHS UL1 RR024975-01NHLBI NIH HHS F32 HL104965NHLBI NIH HHS F32HL104965NHLBI NIH HHS R01 HL070715NHLBI NIH HHS R01 HL105731NHLBI NIH HHS R01HL105731-01A1NHLBI NIH HHS R01HL70715-09
6 · The paper itself

Abstract

importanceLong-term patency of human saphenous veins (HSVs) used as autologous conduits for coronary artery bypass grafting (CABG) procedures remains limited because of vein graft failure (VGF). Vein graft failure has been reported to be as high as 45% at 12 to 18 months after surgery and leads to additional surgery, myocardial infarction, recurrent angina, and death. Preparation of HSVs before implantation leads to conduit injury, which may promote VGF.

objectivesTo investigate whether pressure distension during vein graft preparation leads to endothelial injury and intimal thickening and whether limiting intraluminal pressure during pressure distension by using a pressure release valve (PRV) preserves endothelial function and prevents neointima thickening. DESIGN, SETTING, AND

participantsSegments of HSVs were collected in a university hospital from 13 patients undergoing CABG procedures immediately after harvest (unmanipulated [UM]), after pressure distension (after distension [AD]), and after typical intraoperative surgical graft preparation (after manipulation [AM]). Porcine saphenous veins (PSVs) from 7 healthy research animals were subjected to manual pressure distension with or without an in-line PRV that prevents pressures of 140 mm Hg or greater. Endothelial function of the HSVs and PSVs was determined in a muscle bath, endothelial integrity was assessed, and intimal thickening in PSVs was evaluated after 14 days in organ culture. MAIN OUTCOMES AND MEASURES: Endothelial function was measured in force, converted to stress, and defined as the percentage relaxation of maximal phenylephrine-induced contraction. Endothelial integrity was assessed by immunohistologic examination. Neointimal thickness was measured by histomorphometric analysis.

resultsPressure distension of HSVs led to decreased mean (SEM) endothelial-dependent relaxation (5.3% [2.3%] for AD patients vs 13.7% [2.5%] for UM patients; P < .05) and denudation. In the AM group, the function of the conduits was further decreased (-3.2% [3.2%]; P < .05). Distension of the PSVs led to reduced endothelial-dependent relaxation (7.6% [4.4%] vs 61.9% [10.2%] in the control group; P < .05), denudation, and enhanced intimal thickening (15.0 [1.4] µm vs 2.2 [0.8] µm in the control group; P < .05). Distension with the PRV preserved endothelial-dependent relaxation (50.3% [9.6%]; P = .32 vs control), prevented denudation, and reduced intimal thickening (3.4 [0.8] µm; P = .56 vs controls) in PSVs. CONCLUSIONS AND RELEVANCE: Use of a PRV during graft preparation limits intraluminal pressure generated by manual distension, preserves endothelial integrity, and reduces intimal hyperplasia. Integration of this simple device may contribute to improved long-term vein graft patency.

Indexed as

AnimalsBiomechanical PhenomenaCoronary Artery BypassEndothelium, VascularHumansImmunoenzyme TechniquesMuscle, Smooth, VascularOrgan Culture TechniquesPressureRetrospective StudiesSaphenous VeinSwineTime FactorsVasoconstriction

Identifiers

PMID24759942
PMCPMC4102634
OpenAlexW2087710019

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.